ICAM1 and cancer: Because of the relationship between ICAM1 and its ability to promote EMT mechanisms, as well as the stemness, through its ability to activate the transcription factor STAT3 [23], ICAM1 has been identified as a potential therapeutic target for cancer stem cells (CSCs), and it has been proposed as a target in immunotherapy.